Accession Number: | 0001562180-21-005466 |
Date: | 2021-08-19 |
Issuer: | INARI MEDICAL, INC. (NARI) |
Original Submission Date: |
HYKES ANDREW
C/O INARI MEDICAL, INC.
9 PARKER, SUITE 100
IRVINE, CA 92618
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-08-19 | S | 6,900 | d | $72.53 | 180,274 | direct | ||
COMMON STOCK | 2021-08-19 | S | 2,100 | d | $73.06 | 178,174 | direct | ||
COMMON STOCK | 2021-08-19 | 0 | $0.00 | 1,550 | indirect | ||||
COMMON STOCK1 | 2021-08-19 | 0 | $0.00 | 1,550 | indirect | ||||
COMMON STOCK | 2021-08-19 | 0 | $0.00 | 1,550 | indirect | ||||
COMMON STOCK | 2021-08-19 | 0 | $0.00 | 1,000 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 16, 2020. |
f2 | this transaction was executed in multiple trades at prices ranging from $71.92 to $72.91. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f3 | this transaction was executed in multiple trades at prices ranging from $72.92 to $73.19. the price reported above reflects the weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |